Protalix BioTherapeutics (PLX) Q4 2022 Earnings

27FebConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.18
-0.13
-0.09
-0.04

Details

Expected EPS
-0.15
Actual EPS
-0.07
Surprise EPS
0.08
Surprise Percent
+53.33%

Description

Protalix BioTherapeutics (PLX) has reported earnings of -0.07 per share for Q4 2022.

0 Comments

Share your thoughts